Cohort Event Monitoring Study of Pyramax®

Clinical trial NCT03201770 · COMPLETED

Trial details

NCT number: NCT03201770
Sponsor: Shin Poong Pharmaceutical Co. Ltd.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Malaria,Falciparum

Start date: 2017-06-22
Primary completion: 2019-04-10
Enrollment: 8572

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.